Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma
Joanna Zurko(University of Wisconsin–Madison), Alex F. Herrera(City of Hope), Ernesto Ayala(Mayo Clinic in Florida), Mehdi Hamadani(Medical College of Wisconsin), Trent Wang(Sylvester Comprehensive Cancer Center), Tatyana Feldman(Hackensack University Medical Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Frederick L. Locke(Moffitt Cancer Center), Anikó Szabó(University of Wisconsin–Madison), Jeremy Ramdial(The University of Texas MD Anderson Cancer Center), Vaishalee P. Kenkre(University of Wisconsin–Madison), Yago Nieto(The University of Texas MD Anderson Cancer Center), Craig S. Sauter(Memorial Sloan Kettering Cancer Center), Brian Hess(Washington University in St. Louis), Ryan Jacobs(Levine Cancer Institute), Caron A. Jacobson(Dana-Farber Cancer Institute), Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Olalekan O. Oluwole(Vanderbilt University), Utkarsh Acharya(Dana-Farber Cancer Institute), Alexandra Della Pia(Rutgers, The State University of New Jersey), Mazyar Shadman(University of Washington), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Krishna V. Komanduri(University of Miami), Lorenzo Iovino(University of Pisa), Farrukh T. Awan(The University of Texas Southwestern Medical Center), Madiha Iqbal(Mayo Clinic in Florida), Matthew Mei(City of Hope), Robert J. Soiffer(Dana-Farber Cancer Institute), Adam S. Kittai(Icahn School of Medicine at Mount Sinai), Nathan Denlinger(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Nilanjan Ghosh(Levine Cancer Institute), Patrick M. Reagan(University of Rochester), Lihua E. Budde(City Of Hope National Medical Center), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Julio C. Chávez(Moffitt Cancer Center), Nirav N. Shah(Medical College of Wisconsin), Nausheen Ahmed(Health Care Foundation of Greater Kansas City), Ana Alarcón Tomás(Cornell University), Yazeed Samara(City of Hope), Ayesha Hassan(University of Wisconsin–Madison), Michael D. Jain(Moffitt Cancer Center)
Cited by 73
Related Papers
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
|Nature Medicine|2015|1.1k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
|Journal of Clinical Oncology|2020|782
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
|Biology of Blood and Marrow Transplantation|2015|762